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Abstract
PURPOSE: To determine the value of perfusion computed to-
mography (CT) in prediction of the clinical course and late func-
tional outcome in patients with acute ischaemic stroke who had
unremarkable initial brain CT examination.
MATERIAL AND METHODS: Single slice perfusion CT was per-
formed in 55 consecutive patients (27 women, mean age 67 ±
± 11 years) with acute ischaemic stroke within 6 hours (median
2.26 hours) from onset of symptoms. Values of cerebral blood
flow (CBF), cerebral blood volume (CBV), and mean transit time
(MTT) obtained from affected hemisphere were compared to
respective values in non-affected hemisphere (relative parame-
ters). Initial neurological deficits were estimated using NIH Stroke
Scale (NIHSS) score and correlated with perfusion CT values,
employing Spearman rank correlation coefficient (r). Values of
perfusion CT parameters in prediction of functional outcome were
determined by comparing against scores on modified Rankin
Scale (mRS) and Glasgow Outcome Scale (GOS) after three
months of onset of stroke.
RESULTS: All perfusion CT parameters significantly correlated
with initial neurological deficit. The highest correlation with the
NIHSS was found for relative CBF, which correlated better than
absolute CBF (rCBF r = 0.69; CBF r = 0.50, P < 0.001). In
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prediction of favourable outcome (mRS £ 2) the commonly em-
ployed thresholds (in parentheses) and associated sensitivity,
specificity, positive and negative predictive values were: 87%,
44%, 79%, and 58% for CBF (10 ml/min/100 g), 59%, 81%, 88%,
and 49% for rCBF (48%), 49%, 56%, 73%, and 31% for CBV
(2 ml/100 g), 87%, 44%, 79% and 58% for rCBV (60%), 41%,
81%, 84% and 36% for MTT (6 s) and 54%, 81%, 87% and 49%
for rMTT (145%), respectively, while for prediction of excellent
outcome (mRS £ 1), the only statistically significant respective
accuracy measures were for rCBV, 90%, 35%, 60%, 75%, and
for rCBF, 62%, 69%, 69% and 62%.
CONCLUSIONS: In patients within the first 6 hours from stroke
onset, and without a hypodensity sign on initial routine CT ex-
amination, perfusion CT provides quantitative parameters that
correlate well with initial neurological status and late functional
outcome.
Key words: acute ischaemic stroke, computed tomography,
perfusion, outcome assessment, neurological deficit
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Introduction
Neurological deficits associated with regional cerebral is-
chaemia occur when perfusion decreases below 25 mL/100 g per
minute. In the range of 12–25 mL/100 g per minute, the neuronal
tissue preserves its biological integrity, thus restoring perfusion may
allow the tissue to return to normal function [1, 2]. In acute brain
ischaemia, the water content in the tissue increases rapidly caus-
ing regional oedema that can be detected based on low density
using routine computed tomography (CT) [2, 3]. Early brain tissue
hypodensity observed in CT is associated with more severe neu-
rological symptoms, larger infarct volume, and higher risk of sec-
ondary cerebral haemorrhage [4–6]. Development of the CT-de-
tectable oedema, however, may be delayed well beyond the first 6
hours [4, 5].
The information on whether the ischaemic neuronal tissue is
viable and potentially salvageable is crucial for patient manage-
ment and prediction of outcome. Perfusion-CT (PCT) is able to
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differentiate cerebral ischaemia from infracted tissue [7]. The co-
verage of imaged brain hypoperfusion with or without correlation
to observed infarction core was shown to be prognostic for final
infarct size and clinical outcome, even when recanalisation thera-
py was utilized [7–9]. Although brain PCT thresholds of tissue at
risk are well defined, the accuracy of cerebral blood flow mea-
surements using PCT in prediction of clinical outcomes is still
poorly determined.
The purpose of this study was to explore the relationship be-
tween clinical state and PCT parameters in the acute phase
(< 6 hours) of ischaemic stroke in patients whose routine emer-
gency CT did not show signs of hypodensity. We also compared
the value of established prognostic perfusion thresholds with ours
as determined with PCT for delayed functional outcome.
The principal acronyms of Perfusion-CT and clinical scales used
in the following text are shown on Table 1.
Material and methods
Patients
We included patients who were consecutively referred to our
Stroke Unit over a period of 3 years (2003–2005). The inclusion
criteria were: (1) clinical diagnosis of acute stroke, with (2) stroke
onset less than 6 hours previously, and (3) absence of early hy-
podense changes in routine initial non-contrast CT. Patients with
evidence of intracranial haemorrhage, contraindications to PCT or
to contrast media, acute respiratory or circulatory insufficiency,
neoplasm in case history, or qualified for thrombolytic treatment
were excluded.
Clinical assessment on admission and during 3-month follow-
up was carried out prospectively and included: demographic data,
risk factors, current stroke and imaging timing, neurological pre-
sentation on admission, day 1 and day 7 measured on the Nation-
al Institute of Health Stroke Scale (NIHSS),and functional outcome
on day 90 measured using modified Rankin Scale (mRS) and Glas-
gow Outcome Scale (GOS).
The research protocol was approved by the local Ethical Com-
mittee. Each patient or designated decision-maker gave informed
consent.
Perfusion computed tomography
Perfusion computed tomography (PCT) examinations were
performed on a GE HiSpeed (GE Medical Systems, Milwaukee,
USA) scanner immediately after routine non-contrast CT, in one 10
mm layer, according to accepted protocol. The level of the exam-
ination was chosen in relation to the clinical symptoms, and was
positioned parallel to the orbitomeatal plane and above the orbital
roof to protect eye lenses from radiation. A detailed PCT protocol
is given in Table 2.
Collected imaging data were transferred to a diagnostic work-
station where calculations for selected PCT modalities — mean
transit time (MTT), cerebral blood flow (CBF), and cerebral blood
volume (CBV) — were populated automatically using a Central Vol-
ume Principle deconvolution algorithm with commercial software
delivered by the scanner manufacturer (GE Medical Systems, Mil-
waukee, USA).
Imaging review
Imaging data were elaborated using routine protocol by the
neruoradiologist on duty, who was experienced in PCT, was not
blinded to information about the side of the ischaemic incident, but
was blinded to other clinical data. Pre-prepared, manually drawn
template of regions of interest (ROIs), discriminating all territories
of supratentorial vascularisation of the main cerebral arteries (an-
terior, middle, and posterior), was placed primarily in the affected
hemisphere, and, in an automated way, mirrored ROIs were gen-
erated in the contralateral hemisphere as a reference. The mea-
surements concerned whole imaged brain sections, not only visu-
ally selected regions of hypoperfusion. Averaged within particular
ROIs, values of perfusion parameters in both hemispheres were
calculated in all ROIs, direct values on the affected side, and rela-
tive to the contralateral hemisphere values of each PCT parameter
(given with initial r) were used in further analysis.
Statistical analysis
Measurements from both hemispheres were compared using
a paired 2-sided t test after checking for normality of distributions.
Spearman’s R rank correlation test with t test of significance was
used to analyze the relationship between early brain perfusion dis-
Table 1. Principal acronyms of Perfusion-CT and clinical scales used in text
Acronym Term Units or values
CBF Cerebral Blood Flow — the blood supply to the brain in a given time, in PCT measured in millilitres ml 100g–1 min–1
of blood per 100 grams of brain tissue per minute
CBV Cerebral Blood Volume — the blood amount in a given brain area, in PCT measured in millilitres ml 100g–1
of blood per 100 grams of brain tissue
MTT Mean Transit Time — the time in which venous contrast bolus passes through brain vasculature S
during PCT examination
GOS Glasgow Outcome Scale — a descriptive scale of gross outcome in acute illness, consists 1–5 pts
of five categories: dead, vegetative state, severely disabled, moderately disabled, and good recovery
mRS Modified Rankin Scale — a scale for measuring the degree of disability or dependence in the daily activities 0–6 pts
of people who have suffered a stroke
NIHSS National Institutes of Health Stroke Scale — an assessment tool providing a quantitative measure 0–42 pts
of stroke-related neurologic deficit, most often used in the acute phase of stroke
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turbances in PCT and early neurological deficit measured by NIH-
SS, as well as with 3-month outcome measured by mRS and GOS
scales. This was analyzed for each PCT parameter and was treat-
ed as a continuous variable.
To assess sensitivity, specificity, positive predictive value (PPV),
and negative predictive value (NPV) of PCT imaging in relation to
3-month outcome measured in mRS, each PCT parameter was
dichotomized with arbitrary accepted thresholds adopted from
current literature, differentiating infarction from non-infarction:
CBV < 2.0 ml/100 g, rCBV < 60%, CBF < 10 ml/min/100 g,
rCBF < 48%, and expressing significant and nonsignificant regional
brain ischaemia: MTT > 6 s, rMTT > 145% [7, 10, 11]. Analyses
concerned stroke outcome measured by mRS in two functional
conditions: an excellent outcome with no disability (90-day mRS
dichotomized to score £ 1 and > 1) and independent functional
outcome with slight disability (90-day mRS dichotomized to score
£ 2 — as favourable, and > 2 — as unfavourable outcome), using
Fisher’s exact test.
A P value < 0.05 indicated statistical significance (SYSTAT for
Windows [Microsoft®]; SYSTAT Software Inc. Chicago, IL, USA).
Results
Based on emergency CT examination, ischaemic stroke was
diagnosed in 879 patients out of 1107 consecutive patients referred
to our Stroke Unit in the period 2003–2005 with initial suspicion of
acute stroke. In the ischaemic stroke group, PCT examination was
performed in 86 patients admitted within six hours of  onset of symp-
toms. We excluded from further analysis three patients with neo-
plasmatic illness diagnosed following observation, four with differ-
ent diagnoses than stroke, seven with TIA, four in whom the time of
onset of symptoms was uncertain, four because of treatment with
rt-PA, and two patients because they were transferred to another
hospital and were lost to follow-up. A further seven patients were
excluded because hypodense areas of brain parenchyma were
detected on emergency CT.
Finally, we analyzed data from 55 patients (27 women), with
mean age 67 ± 11 years (range, 36 to 82 years). Median time from
symptoms onset to PCT was 2.26 hours (interquartile range 1.53
to 4.91 hours), median NIHSS on admission was 8.0 (interquartile
range 5.5 to 11.5), and at 7 days (or earlier discharge) was 5.0
(interquartile range 2.0 to 9.0). Arterial hypertension was reported
in 76.4% of patients, ischaemic heart disease in 63.6%, previous
stroke in 10.9%, TIA in 7.3%, previous myocardial infarction in 14.5%,
atrial fibrillation in 30.9%, diabetes mellitus in 23.6%, and hyperlip-
idaemia in 21.8%.
Significant differences of mean registered values between both
hemispheres in all analyzed PCT parameters were observed (Ta-
ble 3). No significant statistical difference between sex subgroups
was found in age, known risk factors of ischaemic stroke, regis-
tered values of cerebral blood flow in affected and non-affected
hemispheres, initial and follow-up clinical state, or mean values of
circulation parameters (blood pressure and heart rate; Student’s
t-test, P > 0.05). Additionally, time from onset of symptoms to PCT
study, and circulation parameters in time of imaging examination,
such as blood pressure and heart rate, did not influence the PCT
results in any observed parameters (Spearman’s rank correlation,
P >0.05).
Table 4 presents the result of analysis of the correlation be-
tween initial cerebral flow disturbances observed in all selected PCT
parameters and neurological deficit on admission, on days 1 and
7 measured by NIHSS, and with degree of disability at day 90
measured by mRS and GOS. Neurological deficit severity on ad-
mission and during hospital observation significantly correlated with
all direct and relative PCT parameters, although at day 90 func-
tional outcome significantly correlated only with initial CBF and all
relative PCT parameters. Relative values (r) of selected PCT pa-
rameters, calculated as percentages of the values registered in
the contralateral hemisphere, demonstrated notably higher corre-
lation with the degree of initial neurological deficit and final disabil-
ity intensity than absolute values, with rCBF showing the strongest
correlation denoted by the highest R statistic.
Table 2. Perfusion CT imaging protocol performed immediately
after routine non-contrast CT
Scanner GE HiSpeed
(GE Medical Systems, Milwaukee, USA)
Rows of detectors 2 n
Layer thickness 10 mm
Number of lamp rotations 45
Number of scans 45 (1 scan per 1 lamp rotation — 1 s)
Time of examination 50 s
Acquisition parameters 80 kVp, 190 mAs
Matrix 512 ¥ 512
Contrast media Iodine, noionic, 350 mg/ml
(Omnipaque®, Amersham Health, USA)
Contrast volume 50 ml
Speed of infusion 4–5 ml/s
Time of infusion 10–12 s
Contrast route Intravenous
Time delay to scanning start 5 s (from contrast infusion start)
Table 3. Mean cerebral perfusion values in affected and non-affected hemispheres observed in PCT in patients with acute ischaemic stroke
at time < 6 hours from onset of symptoms and without parenchymal hypodensity in routine initial non-contrast CT
PCT parameter Affected hemisphere Non-affected hemisphere
Mean (–95% CI – +95% CI; SD)
CBV [ml/100g]* 2.35 (1.80–2.90; 2.03) 2.88 (2.42–3.34; 1.70)
CBF [ml/100g/min]** 25.92 (20.45–31.39; 20.23) 54.88 (44.54–65.22; 38.25)
MTT [s]** 10.58 (8.81–12.35; 6.55) 4.61 (3.50–5.72; 4.10)
CBV — cerebral blood volume; CBF — cerebral blood flow; MTT — mean transit time; CI — confidence interval; SD — standard deviation; *P < 0.05; **P < 0.001 (n = 55; paired
2-sided t test)
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The prognostic value of initial PCT for 3-month functional out-
come measured with mRS in ischaemic stroke patients is present-
ed in Table 5. Accepted brain perfusion thresholds observed in
PCT were better predictors for favourable than for excellent out-
come, with high sensitivity and positive predictive value. Relative
values of observed PCT parameters were clearly better predictors
than absolute values, with statistically significant differences for
favourable outcome in all relative parameters, and for excellent
outcome in rCBV and rCBF.
Discussion
This study demonstrates the significant clinical usefulness of
local cerebral perfusion measurements performed with PCT in
acute ischaemic stroke patients, in which routine emergency CT
does not detect hypodensity. It was reported that the extent of
initial brain hypointensity in routine CT significantly correlates with
NIHSS and mRS [4, 6]; however, in many cases, adequate local
brain infarction oedema is not observed in first CT and hypointense
areas arise later than in the first 6 hours after artery occlusion [4].
Initial NIHSS evaluation is an important prognostic factor for cli-
nical change [12] and for further outcome [13], but in clinical prac-
tice, in cases with normal initial CT results, prognosis may be
based solely on baseline clinical presentation, or have to be sup-
plemented by other studies. We have determined that the rela-
tionship between initial clinical presentation and observed in PCT
early cerebral ischaemic deficit may enhance the prediction of
clinical course and functional outcome in patients not treated with
thrombolysis. Widely used measures of disability after stroke are
mRS or Barthel Indexes [14]; nevertheless, we observed signifi-
cantly better correlation with GOS than with mRS, which was prob-
ably associated with better distinction of exact degree of disabi-
lity in this rating tool. We have shown that in patients without early
hypodense changes in CT imaging, clinical evaluation may be
supplemented by measurement of actual cerebral perfusion de-
ficit, and presumably can help with judgment of forthcoming
changes in unclear cases like progressive stroke or in case of
transient ischaemic attack (TIA).
High sensitivity and specificity of PCT in the diagnostics of
cerebral ischaemia have been reported, mainly in differentiation
of infarction cores from tissue at risk [7]. An evaluation of the ex-
tent of local cerebral blood flow disturbances with PCT is useful in
the prognosis of final infarction size, and the proportion of pe-
numbral and ischaemic core coverage may be prognostic to cli-
nical outcome [15]. An association between PCT parameters and
clinical state has been reported previously; however, there are
still a small number of studies exploring the direct relationship
between initial blood flow reduction and remote functional out-
come, and they are based only on small groups of patients, and
usually in a longer time window [8, 16]. For the delayed progno-
sis, the thresholds of perfusion that we adopted from literature
were better predictors of independent (mRS 0–2) than of excel-
Table 5. Prognostic value of observed PCT parameters for 3-month functional outcome
Outcome PCT Sensitivity Specificity PPV NPV
Excellent mRS £ 1 CBV 51.7% 57.7% 57.7% 51.7%
rCBV * 89.7% 34.6% 60.5% 75.0%
CBF 86.2% 30.8% 58.1% 66.7%
rCBF * 62.1% 69.2% 69.2% 62.1%
MTT 37.9% 69.2% 57.9% 50.0%
rMTT 51.7% 65.4% 62.5% 54.8%
Favourable mRS £ 2 CBV 48.7% 56.3% 73.1% 31.0%
rCBV * 87.2% 43.8% 79.1% 58.3%
CBF * 87.2% 43.8% 79.1% 58.3%
rCBF * 59.0% 81.3% 88.5% 44.8%
MTT 41.0% 81.3% 84.2% 36.1%
rMTT * 53.8% 81.3% 87.5% 41.9%
PPV — positive predictive value; NPV — negative predictive value; CBV — cerebral blood volume; CBF — cerebral blood flow; MTT — mean transit time; mRS — modified Rankin
Scale. Parameters with (r) indicate relative to contralateral hemisphere values respectively [n = 55; Fisher’s exact test (two-tail); *P < 0.05]
Table 4. Relationship between brain perfusion disturbances in PCT (<6 hours from onset) and observed neurological early deficit and func-
tional outcome in patients with acute ischaemic stroke and without parenchymal hypodensity in initial non-contrast CT
PCT NIHSS Day 0 NIHSS Day 1 NIHSS Day 7 or discharge mRS Day 90 GOS Day 90
CBV –0.32* –0.37* –0.36* –0.24 0.27*
rCBV –0.37* –0.38* –0.45* –0.37* 0.41*
CBF –0.50† –0.50† –0.50† –0.34* 0.39*
rCBF –0.69† –0.62† –0.64† –0.47† 0.52†
MTT 0.40* 0.37* 0.39* 0.25 –0.28*
rMTT 0.49† 0.39* 0.43* 0.28* –0.34*
CBV — cerebral blood volume; CBF — cerebral blood flow; MTT — mean transit time; mRS — modified Rankin Scale; NIHSS — National Institute of Health Stroke Scale;
GOS — Glasgow Outcome Scale. Parameters with (r) indicate relative to contralateral hemisphere values respectively. Negative correlation is marked with minus (–) sign;
*P < 0.05; †P < 0.001. (n = 55; Spearman’s rank correlation with t test of significance; R statistic)
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lent (mRS 0–1) outcome. The sensitivity and positive predictive
value of direct measurements were high and statistically signifi-
cant for favourable outcome only in CBF (87.2% and 79.1%, res-
pectively). However, in relation to the contralateral hemisphere,
all the parameters reached statistical significance. The specificity
and negative predictive value were only satisfactory, probably due
to the small sample size and limited brain amount imaged. More-
over, most authors underline that absolute values of cerebral per-
fusion in PCT do not illustrate exact cerebral blood flow; only
Positron Emission Tomography (PET) is the accepted method of
correct ischaemic threshold estimation [17, 18]. Direct values of
CBF and CBV may substantially differ depending on various fac-
tors, e.g. they show near 20% individual variability, and gradual
reduction with age [19, 20], and because of this, the relative eval-
uation of registered values with the contralateral (non-affected)
hemisphere is of higher significance in every available parameter
[8, 10]. In our study relative (r) parameters also demonstrated
stronger correlation with clinical state, and the dependence of
external factors or age was not confirmed.
The method we used in PCT analysis may raise a few technical
issues, although we designed it from a clinical, not radiological
perspective and aimed to shorten the time of analysis. In routine
clinical practice, volumetric assessment of the ischaemic core and
penumbra involves time-consuming calculations and may be diffi-
cult in an emergency setting. Furthermore, depending on the soft-
ware used, the results of the PCT may be presented in various
colourful maps, with different colours indicating different blood flows
[21], and the decision of whether an exact part of the brain tissue is
still viable or irreversibly infracted is based on the subjective visual
judgment of a radiologist using software-presupposed thresholds.
To simplify the procedure we have prepared a template of ROIs
covering a whole imaged brain section, discriminating all territo-
ries of vascularisation of the main cerebral arteries in both hemi-
spheres, delivering exact values of perfusion parameters, averaged
within particular ROIs, and compared between hemispheres. This
procedure was quick and easy to use, even by a technician. Addi-
tionally, in our analysis we adopted perfusion thresholds from cur-
rent literature, because we were unable to reliably establish our
own thresholds due to the fact that we only had initial PCT results
without the following imaging control verifying localization of mea-
surements. According to the WHO definition of stroke [22], the fi-
nal diagnosis of ischaemic stroke is not radiological but clinical,
and, following the guidelines, this was a matter of routine pragmat-
ics, where, in the majority of patients, after initial CT excluding hae-
morrhage, the subsequent examinations are not performed if it is
not definitely necessary.
Application of cerebral perfusion studies have been proposed
as a useful additional tool in the thrombolytic treatment qualifica-
tion process [23, 24]. The results of rt-PA therapy in acute stroke
are not only dependent on time from artery occlusion to recanali-
sation, but first of all on the proportion of the extent of penumbra
and infarction size [25–27]. We did not observe patients treated
with thrombolysis because our study started before this treatment
was approved in the EU and Poland, but the protocol assumed the
inclusion patients potentially eligible for thrombolysis. On the other
hand, even if the treatment window for thrombolysis in acute is-
chaemic stroke is widening [28, 29], there is still, proportionally,
a tremendous number of patients excluded from rt-PA therapy,
requiring appropriate monitoring and control of clinical changes
and effects of conservative treatment.
PCT is a well-tolerated study that is not time-consuming, and
it can easily be integrated with routine CT in standard imaging
processes in the acute stroke setting in all patients; however,
a few disadvantages of this technique should be noted. Exami-
nation of PCT, depending on the scanner, may be performed only
in a limited region of the brain (1–4 cm thick layer), and due to
this, the exact localization of the ischaemic process can be omit-
ted. In our study this was a 1 cm thick layer, and localization of
the performed measurements (ROIs) was not controlled by fol-
low-up imaging evaluation. Furthermore, PCT technique favours
supratentorial strokes, and therefore patients with circulation de-
ficits in the vertebro-basilar region are under-represented in most
studies.
Conclusions
In acute stroke patients with normal CT results within the first 6
hours, direct values of local cerebral perfusion derived from brain
PCT show good correlation with initial neurological status and may
help in the prognosis of late functional outcome. Acute ischaemic
stroke patients with normal routine initial CT results and PCT val-
ues lower than accepted, perfusion thresholds for brain ischaemia
have a less favourable clinical course.
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